Advertisement

Topics

FDA Approves Drug Treatment to Prevent Migraines

18:26 EDT 14 Sep 2018 | Pharmacy Times

Officials with the FDA have approved fremanezumab-vfrm (Ajovy, Teva) for the preventive treatment of migraine in adults.

Original Article: FDA Approves Drug Treatment to Prevent Migraines

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Drug Treatment to Prevent Migraines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...